Form 4: Medtronic EVP Wall Reports Routine Share Withholding
Insider Transaction Report
Medtronic EVP Brett A. Wall reported the withholding of 439 ordinary shares for tax purposes related to restricted stock unit vesting.
Summary
- Brett A. Wall, Executive Vice President and President of Neuroscience at Medtronic plc, reported a transaction on December 15, 2025.
- 439 ordinary shares were disposed of at a price of $99.87 per share.
- This disposition represents shares withheld for the payment of taxes upon the vesting of restricted stock units, a transaction triggered by Mr. Wall's retirement eligibility.
- Following this reported transaction, Mr. Wall beneficially owns 54,749 ordinary shares.
- The total beneficial ownership includes 251 shares acquired through dividend reinvestment since the last report filed by Mr. Wall.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving tax withholding upon restricted stock unit vesting, which is a standard part of executive compensation and does not indicate a significant positive or negative sentiment regarding the company's performance or outlook.
Positives
- The reporting person acquired 251 shares through dividend reinvestment, indicating continued investment in the company.
- The transaction relates to the vesting of restricted stock units, which is a positive event for the executive as it represents earned compensation.
Negatives
- 439 ordinary shares were disposed of, reducing the reporting person's direct beneficial ownership.
Industry Context
This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitive landscape.
Key Dates
| Date | Description |
|---|---|
| 12/15/2025 | Date of transaction where shares were withheld for tax upon RSU vesting. |
| 12/17/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 reports a routine tax withholding transaction related to executive compensation and does not provide new information that would alter the fundamental investment thesis for Medtronic plc. Therefore, a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Medtronic, MDT, Form 4, Insider Transaction, Stock Withholding, Executive Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.